Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Overexpression of the αvβ6 Integrin in Endometrial Cancer

Overexpression of the αvβ6 Integrin in Endometrial Cancer RESEARCH ARTICLE Overexpression of the avb6 Integrin in Endometrial Cancer Jonathan L. Hecht, MD, PhD,* Brian M. Dolinski,w Humphrey A. Gardner, MD,w Shelia M. Violette, PhD,w and Paul H. Weinreb, PhDw role in tumor proliferation, survival, invasion, and 3–7 Abstract: The alpha(v)beta(6) integrin (avb6) has been shown to metastasis. be up-regulated in adenocarcinoma of the breast, colon, avb6 has expression restricted to epithelial cells and stomach, and ovary, generally reflecting a more aggressive has been shown to be up-regulated in areas of wound 2,8,9 phenotype. Expression in endometrial cancer has not been healing and in neoplasms, including oral squamous reported. We analyzed avb6 expression in the tissue from carcinoma and adenocarcinomas of the breast, colon, primary endometrial carcinomas (endometrioid type) using a stomach, and ovary, generally reflecting a more aggres- 3,7,10–14 mouse monoclonal antibody against human avb6, and corre- sive phenotype. We used monoclonal antibodies lated the findings with grade, stage, and nodal involvement. specific for avb6 15 to evaluate expression in normal Normal cycling endometrium was studied for comparison. avb6 cycling endometrium and endometrial carcinoma in was only weakly expressed in normal epithelium and infre- relation to grade and stage. quently expressed in precancers, but up-regulated in the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Overexpression of the αvβ6 Integrin in Endometrial Cancer

Loading next page...
 
/lp/wolters-kluwer-health/overexpression-of-the-alpha-v-beta-6-integrin-in-endometrial-cancer-0zzffBRv0Q

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1062-3345
eISSN
1533-4058
DOI
10.1097/PAI.0b013e31816bc5ee
pmid
18698261
Publisher site
See Article on Publisher Site

Abstract

RESEARCH ARTICLE Overexpression of the avb6 Integrin in Endometrial Cancer Jonathan L. Hecht, MD, PhD,* Brian M. Dolinski,w Humphrey A. Gardner, MD,w Shelia M. Violette, PhD,w and Paul H. Weinreb, PhDw role in tumor proliferation, survival, invasion, and 3–7 Abstract: The alpha(v)beta(6) integrin (avb6) has been shown to metastasis. be up-regulated in adenocarcinoma of the breast, colon, avb6 has expression restricted to epithelial cells and stomach, and ovary, generally reflecting a more aggressive has been shown to be up-regulated in areas of wound 2,8,9 phenotype. Expression in endometrial cancer has not been healing and in neoplasms, including oral squamous reported. We analyzed avb6 expression in the tissue from carcinoma and adenocarcinomas of the breast, colon, primary endometrial carcinomas (endometrioid type) using a stomach, and ovary, generally reflecting a more aggres- 3,7,10–14 mouse monoclonal antibody against human avb6, and corre- sive phenotype. We used monoclonal antibodies lated the findings with grade, stage, and nodal involvement. specific for avb6 15 to evaluate expression in normal Normal cycling endometrium was studied for comparison. avb6 cycling endometrium and endometrial carcinoma in was only weakly expressed in normal epithelium and infre- relation to grade and stage. quently expressed in precancers, but up-regulated in the

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: Dec 1, 2008

There are no references for this article.